faculty photo

X. Long Zheng, M.D, Ph.D

Associate Professor of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
Abramson Research Center 816G
The Children's Hospital of Philadelphia
The 34th Street & Civic Center Blvd,
Philadelphia, PA 19104
Office: (215) 590-3565
Fax: 267-426-5165
Education:
M.D. (Medicine)
Nanchang University Medical College, Nanchang, China, 1984.
Ph.D. (Molecular and Cell Biology)
Medical University of Vienna, Vienna, Austria, 1994.
Residency (Clinical Pathology)
Washington University School of Medicine, St. Louis, MO, 2002.
Fellowship (Transfusion Medicine)
Washington University School of Medicine, St. Louis, MO, 2003.
Permanent link
 

Selected Publications

Jian C, Xiao J, Gong L, Skipwith C, Jin S-Y, Kwaan H-C, and Zheng X. : Gain-of-function ADAMTS13 variants that are resistant to inhibition by autoantibodies in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Blood (in press) Page: doi:10.1182/blood-2011-12-399501, January 2012.

Xiao J., Jin S-Y., Xue J., Sorvillo N., Voorberg J., and Zheng X.L.: Essential Domains of ADAMTS13 Metalloprotease Required for Modulation of Arterial Thrombosis. Arterioscler. Thromb. Vasc. Biol. 31: 2261-2269, October 2011

Li D., Xiao J., Paessler M., and Zheng X.L.: Novel Recombinant Glycosylphosphatidylinositol (GPI)-Anchored ADAMTS13 and Variants for Assessment of Anti-ADAMTS13 Autoantibodies in Patients with Thrombotic Thrombocytopenic Purpura. Thromb Haemost 106 (5): 947-58. November 2011.

Skipwith C., Cao W., and Zheng X.L.: Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress. J Biol Chem 285(37): 28596-603, September 2010.

Zheng X.L., Wu H.M., Shang D., Falls E., Skipwith C.G., Cataland S.R., Bennett C.L., and Kwaan H.C.: Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica 95(9): 1555-62, September 2010.

Jin S.Y., Skipwith C.G., and Zheng X.L.: Amino acid residues Arg659, Arg660 and Tyr661 in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor Blood 115(11): 2300-2310, March 2010.

Raife T.J., Cao W.J., Atkinson B.S., Bedell B., Montgomery R.R., Lentz S.R., Johnson G.F., and Zheng X.L.: Leukocyte proteases cleave von Willebrand factor near or at the ADAMTS13 cleavage site. Blood 114(8): 1666-74, August 2009.

Laje P., Shang D., Cao W., Niiya M., Endo M., Radu A., DeRagotis N., Scheiflinger F., Zoltick P.W., Flake A.W., and Zheng X.L.: Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy Blood 113(10): 2172-2180, March 2009.

Niiya M., Endo M., Shang D., Zoltick P.W., Muvarak N.E., Cao W.J., Jin S-Y., Skipwith C.G., Motto,D.G., Flake A.W. and Zheng X.L.: Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes. Mol Ther 17(1): 34-41, January 2009.

Cao W.J., Krishnaswamy S., Camire R.M., Lenting P.J., and Zheng X.L.: Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13. Proc Natl Acad Sci USA 105(21): 7416-7421, May 2008.

back to top
Last updated: 01/31/2012
The Trustees of the University of Pennsylvania
 

» Top